Pivotal Bio Venture Partners Investment Advisor LLC Fusion Pharmaceuticals Inc. Transaction History

Pivotal Bio Venture Partners Investment Advisor LLC

$111 Million
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$7.9 - $21.32 $7.88 Million - $21.3 Million	-997,597 Reduced 63.91%	563,385 $12 Million
Q1 2023 May 12, 2023	SELL	$3.03 - $5.13 $6 - $10	-2 Reduced -0.0%	1,560,982 $5.88 Million
Q3 2022 Nov 10, 2022	BUY	$2.0 - $3.56 $4 - $7	2 Added 0.0%	1,560,984 $4.7 Million
Q2 2022 Aug 12, 2022	SELL	$2.49 - $7.86 $93,113 - $293,924	-37,395 Reduced 2.34%	1,560,982 $3.89 Million
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.78 $8 - $15	-2 Reduced -0.0%	1,598,377 $6.51 Million
Q3 2021 Nov 15, 2021	BUY	$7.83 - $9.41 $15 - $18	2 Added 0.0%	1,598,379 $12.7 Million
Q2 2021 Aug 16, 2021	SELL	$7.97 - $10.66 $15 - $21	-2 Reduced -0.0%	1,598,377 $12.6 Million
Q4 2020 Feb 09, 2021	BUY	$11.5 - $13.73 $18.4 Million - $21.9 Million	1,598,379 New	1,598,379 $18.8 Million

Others Institutions Holding FUSN

# of Institutions

Shares Held

93K

Call Options Held

1.4K

Put Options Held

View Full List

About Fusion Pharmaceuticals Inc.

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

More about FUSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.

Account